Kamada Ltd. (KMDA)
8.42
+0.18
(+2.18%)
USD |
NASDAQ |
Aug 24, 16:00
8.42
0.00 (0.00%)
After-Hours: 20:00
Kamada Shareholders Equity (Quarterly) : 269.56M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 269.56M |
| March 31, 2026 | 259.39M |
| December 31, 2025 | 269.07M |
| September 30, 2025 | 265.23M |
| June 30, 2025 | 259.95M |
| March 31, 2025 | 251.96M |
| December 31, 2024 | 259.46M |
| September 30, 2024 | 255.27M |
| June 30, 2024 | 251.15M |
| March 31, 2024 | 246.51M |
| December 31, 2023 | 244.02M |
| September 30, 2023 | 238.39M |
| June 30, 2023 | 176.75M |
| March 31, 2023 | 174.81M |
| December 31, 2022 | 176.02M |
| September 30, 2022 | 172.55M |
| June 30, 2022 | 171.57M |
| March 31, 2022 | 175.15M |
| December 31, 2021 | 176.82M |
| September 30, 2021 | 181.61M |
| June 30, 2021 | 182.34M |
| March 31, 2021 | 181.22M |
| December 31, 2020 | 178.64M |
| September 30, 2020 | 176.73M |
| June 30, 2020 | 169.76M |
| Date | Value |
|---|---|
| March 31, 2020 | 165.82M |
| December 31, 2019 | 135.32M |
| September 30, 2019 | 130.14M |
| June 30, 2019 | |
| March 31, 2019 | 117.47M |
| December 31, 2018 | 112.38M |
| September 30, 2018 | 93.92M |
| June 30, 2018 | 95.90M |
| March 31, 2018 | 90.11M |
| December 31, 2017 | 89.49M |
| September 30, 2017 | 83.71M |
| June 30, 2017 | 68.34M |
| March 31, 2017 | 63.22M |
| December 31, 2016 | 66.74M |
| September 30, 2016 | 68.67M |
| June 30, 2016 | 69.39M |
| March 31, 2016 | 70.87M |
| December 31, 2015 | 72.51M |
| September 30, 2015 | 69.97M |
| June 30, 2015 | 74.12M |
| March 31, 2015 | 74.67M |
| December 31, 2014 | 79.27M |
| September 30, 2014 | 76.38M |
| June 30, 2014 | 78.43M |
| March 31, 2014 | 85.69M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| BioLineRx Ltd. | 16.67M |
| XTL Biopharmaceuticals Ltd. | -- |
| Can-Fite BioPharma Ltd. | -- |
| Galmed Pharmaceuticals Ltd. | 13.95M |
| Revium Recovery, Inc. | 18.10M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 383.16M |
| Total Liabilities (Quarterly) | 113.60M |
| Debt to Equity Ratio | 0.0438 |
| Current Ratio | 4.060 |
| Net Debt Paydown Yield | -0.03% |